Where studies actually fail
Configurable eCOA software, or platform-owned outcomes?
YPrime and Delve both offer flexible, fully configurable eCOA. The genuine YPrime-specific value is integrated IRT/RTSM in the same platform, which is a real consolidation win for studies where both are needed. For everything else — recovering a patient who's drifted from wearable wear for three days, validating a wearable algorithm for endpoint submission, running multilingual outreach in 120 languages, or rolling out a study across multiple regions without IT tickets — those are different problems, and they're where Delve specializes.
- Highly configurable enterprise eCOA / ePRO platform
- IRT / RTSM with deep customization options
- Mid-market pharma and biotech sponsors
- Flexible study build for complex protocols
- Traditional site-based trial workflows
Configurable enterprise software. Real flexibility.
- A patient who hasn't worn their device for 3 days
- A wearable producing physiologically implausible data
- An eCOA diary missed in a language the patient speaks at home
- A caregiver overwhelmed in a rare-disease trial
- Endpoint integrity when devices have firmware drift
Patient-facing, cross-cultural, real-world. Configurable eCOA can build any form — it can't guarantee a patient completes it.
- 70+ validated wearable algorithms
- 7-dimension real-time compliance scoring
- Concierge-as-a-Service in 120+ languages
- 92–98% per-study eCOA/ePRO completion
- Up to 63% retention uplift in long-duration cohorts
- UI-driven multi-tenant rollout (US/NA, EU, LATAM, APAC, MENA) — no IT tickets, no per-region procurement
- Open endpoint APIs — REST + webhooks + CDISC + Parquet delivery into your EDC and analytics stack, with versioned contracts and provenance
Platform-owned outcomes. Documented per study.
Bottom line: YPrime and Delve both offer highly configurable eCOA — that's table stakes for either platform, not a YPrime differentiator. YPrime's irreducible strengths are mid-market biotech pricing flexibility, integrated IRT/RTSM, and the new April 2026 AI Calculation Engine for in-house logic builds. If those specific capabilities are decisive, YPrime is a credible pick. For every other dimension — validated wearable algorithm library, real-time 7-dimension compliance scoring, multilingual concierge in 120+ languages, documented per-study completion (92–98%) and retention (up to 63%) outcomes — Delve provides what YPrime doesn't, with the same eCOA configurability you'd expect from either platform.
How Delve actually delivers 92–98% completion
Three engagement layers, not one
Other platforms bet on a single approach: configurable software (YPrime), AI agents (Medable), rater services (Signant), or core-lab pedigree (Clario). Delve combines three engagement layers on top of one validated wearable platform — which is why per-study completion lands at 92–98% vs. the published industry baseline of 80–90%.
Fully featured eCOA you can build any study on. Configurable without engineering tickets.
- Branching logic, edit checks, scheduling, scoring, version control
- Validated PRO / ClinRO / ObsRO / PerfO instrument support
- Pre-built diary templates + form builder for custom protocols
- 120+ language delivery, BYOD or provisioned devices
- UI-driven multi-tenant rollout (US/NA, EU, LATAM, APAC, MENA)
Engagement before patients drift. Built into the platform — not a separate product to license.
- Smart push notifications & configurable reminders
- Adaptive UX that responds to completion patterns
- Multimedia guidance (video, audio, visual prompts)
- Patient app with centralized "For You" task view
- Multilingual prompts in the patient's preferred language
When tech engagement isn't enough — humans recover the patient before data goes missing.
- 120+ languages of trained human concierge
- Documented <24h response windows
- Watch-level alerts triaged before they reach sites
- Caregiver support for rare-disease & pediatric trials
- Device troubleshooting, re-engagement, escalation
Why this combination works: Configurable software alone produces blank forms patients ignore. Engagement alerts alone produce notification fatigue. Human concierge alone is expensive and doesn't scale. The three together, operating on one validated wearable platform, are what produce 92–98% completion in real studies. Every other vendor in this comparison provides one or two of these layers — not three.
Two different bets
Enterprise eCOA configurability, or compliance and retention operating system?
Both platforms can run a regulated trial. The difference is whether the platform partner owns outcomes or just ships software.
Two delivery models
- YPrime's pitch: Configurable eCOA / ePRO with integrated IRT — the consolidation play for mid-market biotech that wants both in one platform. Vendor-reported metrics: 47% faster eCOA startup, ~50% faster IRT startup. Public customer review evidence is thin: zero G2 reviews and minimal third-party validation beyond vendor-sponsored analyst placements.
- YPrime's recent context: December 2024 layoffs accompanied management acknowledgment that eCOA revenue was down. Continues to operate as software-only platform; the customer's clinical operations team owns compliance recovery. Independent customer-review presence remains thin compared to enterprise eCOA peers.
- Delve's strength: 70+ validated wearable algorithms on a harmonized clinical data layer, plus Concierge-as-a-Service in 120+ languages — both owned as platform-delivered compliance and retention outcomes. Different layer than configurable eCOA software.
- Delve's commitment: 92–98% per-study completion ranges and up to 63% retention uplift, documented per study.
- Both YPrime and Delve offer configurable eCOA and patient-facing apps — that's table stakes for either. The real question is what happens after eCOA is configured: who keeps patients in the study, who validates wearable endpoints, who recovers compliance before it drifts. YPrime is software. Delve is software plus the operating layer that determines whether eCOA actually produces data.
Delve-documented eCOA/ePRO completion range, per study.
Up to 63% retention uplift in long-duration cohorts (Delve).
Validated digital-endpoint algorithms across 25+ wearables.
Languages of human concierge, built into the platform.
Where the two platforms genuinely overlap
At the feature checklist level, YPrime and Delve Health each support eCOA, ePRO, eConsent, and analytics. Both can run regulated trials. Both platforms ship:
- Digital informed consent (eConsent) with multimedia and audit trail
- Electronic Clinical Outcome Assessment (eCOA) and patient-reported outcomes (ePRO)
- Wearable and digital health technology integration
- Real-time analytics dashboards for study oversight
- Decentralized and hybrid trial design support
- Full compliance posture: HIPAA, GDPR, 21 CFR Part 11, ICH GCP, ISO 27001
The differences show up only once you ask what happens when compliance starts to drift, when a wearable produces unusable data, or when sites need relief.
Side-by-side comparison
YPrime vs Delve Health: capability comparison
The table below reflects publicly documented capabilities and standard delivery models for each platform. Specific configurations may vary by contract.
| Capability | YPrime | Delve Health |
|---|---|---|
| Outcomes — where studies live or die | ||
| Per-study completion rate accountability | Customer-driven | 92–98% documented per study |
| Retention uplift target | Customer-driven | Up to 63% in long-duration cohorts |
| Validated digital-endpoint algorithms | Configurable eCOA; thin wearable algos | 70+ wearable algorithms across ECG, glucose, activity, sleep, frequency & QC |
| Real-time compliance scoring | Monitoring dashboards | 7-dimension hourly readiness + closed-loop recovery |
| Human concierge patient support | Customer / partner-delivered | Built into platform — 120+ languages, <24h response windows |
| Wearable device support | Partner-driven, limited devices | 25+ devices on harmonized clinical data layer |
| Site burden reduction | Site portal + dashboards | Concierge triages alerts before sites see them |
| Architecture & speed to launch globally | ||
| Multi-region tenant rollout | Standard SaaS; multi-region not self-serve | UI-driven multi-tenant — spin up region-aware tenants (US/NA, EU, LATAM, APAC, MENA) without IT tickets or per-region procurement |
| Diary & eCOA template library | eCOA Builder; no public validated diary template library | Pre-built diary templates for rapid eCOA build, plus configurable form builder for custom protocols |
| Self-serve admin platform | Vendor-administered, ticket-based for changes | Admin UI for tenant management, user roles, audit log, diary template library |
| API & EDC / analytics integration | SaaS APIs available; complex integrations typically via professional services | Endpoint APIs with lineage — REST pull + webhook push + batch + CDISC packages + Parquet, with versioned contracts, provenance, audit trail and direct EDC delivery |
| Built-in audit log accessible to sponsors | Available on request from vendor | Live admin UI — sponsors and CROs can self-audit |
| Configurability — where YPrime focuses | ||
| Highly configurable eCOA / ePRO | Yes — flexible study build | Yes — multilingual eCOA with concierge |
| IRT / RTSM (interactive response / randomization) | Yes — built-in | Partner integration |
| Mid-market pharma / biotech fit | Yes — primary segment | Yes — outcomes-focused engagement |
| Shared baseline | ||
| eCOA / ePRO platform | Yes | Fully configurable eCOA — adaptive UX, branching logic, multimedia, 120+ languages, validated PRO/ClinRO/ObsRO/PerfO instruments, version control without engineering tickets |
| Patient engagement model | Configurable reminders + Participant Hub; sponsor-managed engagement | Multi-layered — smart reminders + adaptive UX + multimedia guidance + multilingual prompts + human concierge in 120+ languages when tech isn't enough |
| eConsent | Yes | Yes — multimedia with audit trail |
| Telehealth & video visits | Partner integration | Yes — built into platform |
| Compliance posture (HIPAA, GDPR, 21 CFR Part 11, ICH GCP, ISO 27001) | Yes | Yes |
| Engagement model | ||
| Pricing model | SaaS license + setup + professional services | Outcomes-scoped integrated engagement |
| Accountability for outcomes | Customer's clinical operations team | Delve owns drift recovery between visits |
| Strongest fit | Mid-market pharma / biotech with highly customized eCOA requirements | Wearable-heavy, long-duration, hybrid-trial, or compliance-critical studies |
Why outcomes-grade studies pick Delve over YPrime
Four reasons sponsors pick Delve when their trial is wearable-heavy, multilingual, or compliance-fragile — where configurable eCOA software isn't the binding constraint.
Completion guaranteed, not hoped for
Delve publishes documented 92–98% per-study eCOA/ePRO completion ranges as a platform deliverable. YPrime provides tools; the customer's clinical operations team owns the completion number. Different accountability models.
Your algorithm, not the device's
70+ validated digital-endpoint algorithms across ECG, glucose, activity, sleep, frequency, and QC — running on Delve's harmonized data layer, not consumer-grade vendor SDKs. Endpoint integrity is engineered, not assumed.
Humans recover patients. Period.
Patient drift gets recovered by trained humans in 120+ languages, not chatbots. AI agents handle internal paperwork well; they don't solve a caregiver in a rare-disease trial who's burned out, or a non-native speaker confused by an ePRO prompt.
Hourly readiness, not weekly reports
7-dimension compliance scoring updated every hour. YPrime's dashboards surface monitoring data; Delve's readiness scoring is designed to recover drifting patients before data goes missing.
1. Human concierge vs. customer-driven recovery
YPrime delivers patient-facing support through its software platform plus (where needed) professional services or partners. Multilingual outreach, proactive compliance follow-up, and real-time recovery operations are typically handled by the sponsor's clinical operations team or contracted vendors.
Delve includes Concierge-as-a-Service as a built-in platform layer, with humans operating in 120+ languages, with documented response windows and escalation rules. The model targets the compliance loss that happens between visits — missed diaries, device confusion, wear-time decay — through trained humans, not chatbots.
Why it matters: in real-world studies, the majority of compliance loss does not show up in monitoring reports — it shows up in patient confusion, missed reminders, and device issues that need human follow-through. Whoever owns that follow-through determines completion rates.
2. Wearable platform depth
YPrime integrates with selected wearables and relies more heavily on vendor-supplied metrics. Delve runs 70+ validated digital-endpoint algorithms across 25+ supported devices on a harmonized clinical data layer that normalizes units, sampling rates, time bases, QC flags, and algorithm versions.
The data-layer engineering is the part most evaluators miss. Two vendors can both “support wearables” and have very different validation evidence behind the data each platform produces.
Why it matters: for wearable-heavy studies, endpoint integrity depends on more than just data ingestion. Validation evidence is part of the submission package.
Which platform fits your study
Choose the platform that fits your operating model
Both platforms run modern clinical trials successfully. The right answer depends on your study profile and your internal operating model.
Choose YPrime if…
- You need integrated IRT / RTSM in the same platform as eCOA — one of YPrime's genuine consolidation strengths
- YPrime's April 2026 AI Calculation Engine for in-house logic builds is a deal-deciding capability for your team
- Your eCOA needs are form-heavy with minimal wearable, multilingual, or retention-recovery requirements
- YPrime's mid-market biotech pricing structure fits your budget better than outcomes-scoped engagements
- You're extending an existing YPrime relationship across additional studies
Choose Delve Health if…
- You're launching a multi-region study and need self-serve UI-driven tenant rollout (US/NA, EU, LATAM, APAC, MENA) without per-region procurement, IT tickets, or pre-built validated diary templates available on day one
- You want the same configurable eCOA YPrime offers, plus 70+ validated wearable algorithms YPrime doesn't have
- Your study is wearable-heavy and endpoint integrity depends on validated digital biomarkers
- You need multilingual human concierge in 120+ languages built into the platform
- You want documented per-study completion (92–98%) and retention uplift (up to 63%) as platform deliverables
- Your protocol is long-duration, complex, or high patient burden — rare disease, oncology, CNS, post-market
- Your compliance loss happens through patient drift between visits — not eCOA configuration limits
Frequently asked questions
Questions sponsors ask when comparing YPrime and Delve Health
These answers clarify the operational differences and how to evaluate them for your protocol.
How is Delve Health different from YPrime?
YPrime is an enterprise eCOA, ePRO, and IRT/RTSM platform known for strong configurability and flexibility in mid-market pharma and biotech. Delve Health is a clinical trial compliance and retention operating system combining 70+ validated wearable endpoint algorithms, real-time 7-dimension compliance scoring, and human Concierge-as-a-Service in 120+ languages, with completion and retention as platform-owned outcomes. The decision usually comes down to: configurable eCOA software, or platform-owned outcomes.
Is YPrime good for complex eCOA configurations?
Yes — YPrime is known for accommodating highly customized eCOA / ePRO requirements with flexible study build options. Delve also handles complex eCOA / ePRO designs (multilingual, multi-modality, hybrid). The question is whether configurability or compliance and retention outcomes are the deliverable you need.
Does YPrime have wearable platform depth?
YPrime supports connected-device integrations at the feature level (e.g., glucometers, BP cuffs) but does not operate a multi-sensor, validated algorithm library — their April 2026 AI moves focused on eCOA configuration, not wearable analytics. Delve runs 70+ validated digital-endpoint algorithms across 25+ wearable devices on a harmonized clinical data layer, operating today.
Does YPrime include human concierge like Delve?
YPrime is a software-led model; multilingual outreach, proactive compliance follow-up, and recovery operations are typically delivered by the sponsor's clinical operations team or a partner. Delve includes Concierge-as-a-Service in 120+ languages as a built-in platform layer with documented response windows.
How do pricing models compare?
YPrime typically prices as SaaS license + study setup + professional services. Delve prices as an integrated outcomes-scoped engagement where eCOA, wearables, analytics, and concierge support are scoped against the trial's compliance and retention outcomes rather than a la carte.
When should I choose YPrime over Delve Health?
Choose YPrime when the priority is highly configurable eCOA software with integrated IRT/RTSM for a mid-market pharma or biotech study with internal clinical operations capacity to drive compliance recovery. Choose Delve when the priority is wearable endpoint integrity, multilingual concierge, real-time compliance scoring, and documented platform-owned completion and retention outcomes.
Related learning
Build a complete picture before you commit
Knowledge pages that help sponsors evaluating eCOA, DCT, and wearable platforms understand what separates execution-grade vendors from platforms that look good in demos.
How to choose an eCOA vendor
Evaluation criteria beyond software — execution, support, compliance, site impact.
Read the guide →eCOA Vendor Comparison framework
Dimensions that predict study performance — used to compare any pair of platforms.
Open the framework →Why eCOA data fails in real-world trials
Missed diaries, patient drift, fragmented systems — hidden failure modes and what fixes them.
Read more →How to measure compliance in clinical trials
A practical, vendor-neutral framework for measuring compliance across modalities.
Read more →Evaluating Delve against your current stack?
If you are comparing YPrime, Delve, or other DCT/eCOA platforms, ask each vendor one question: what happens when a participant stops responding? The answer tells you more than any demo.
Book a Platform Walkthrough